Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS)
National Natural Science Foundation of China [82070217, 81873427, 81770211, 81670152, 81700145]; Key Program of the National Natural Science Foundation of China [81830008, 81630006]; CHEN XIAO-PING Foundation for the Development of Science and Technology of Hubei Province [CXPJJH12000009-113]
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China[2]Huazhong Univ Sci & Technol, Tongji Hosp, Div Cardiol, Dept Internal Med,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China[3]Immunotherapy Res Ctr Hematol Dis Hubei Prov, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Nie Jiali,Yang Li,Huang Liang,et al.Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS)[J].CANCER COMMUNICATIONS.2022,42(5):476-480.doi:10.1002/cac2.12260.
APA：
Nie, Jiali,Yang, Li,Huang, Liang,Gao, Lili,Young, Ken He...&Zhou, Jianfeng.(2022).Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS).CANCER COMMUNICATIONS,42,(5)
MLA：
Nie, Jiali,et al."Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS)".CANCER COMMUNICATIONS 42..5(2022):476-480
医学